Back to search

Virginia Tech

Investigation of Advanced Cavitation Agents for Nanoparticle-Mediated Histotripsy (NMH) Applications

Abstract

dc:description.abstract

Nanoparticle-mediated histotripsy (NMH) is an emerging non-invasive therapy that combines focused ultrasound with engineered nanoparticles to induce controlled acoustic cavitation for the mechanical ablation of targeted tissues. Unlike conventional histotripsy, which relies on endogenous cavitation nuclei and typically requires high negative pressure (>25 MPa), NMH utilizes nanoparticles to initiate cavitation at significantly lower pressures (<15 MPa). This lower threshold not only improves the safety and precision of the therapy but also expands its potential applications across a broader range of tissue types and anatomical sites. As a versatile and tunable platform, NMH offers the ability to integrate multifunctional nanoparticles that enable synergistic capabilities, such as targeted ablation or localized drug delivery, all within a single treatment modality. To date, NMH has demonstrated proof-of-concept success in applications such as prostate cancer ablation and catheter-based biofilm removal. However, its full potential as a multifunctional therapeutic platform for more complex disease environments remains underexplored. In this dissertation, I investigate the feasibility and optimization of NMH for two clinically relevant and challenging scenarios: the treatment of breast cancer and the eradication of biomaterial-associated infections. Specifically, this work focuses on: (1) the characterization of NMH cavitation agents with clinically relevant pulsing parameters, (2) the feasibility of NMH as a breast cancer treatment, and (3) the characterization and feasibility of dual-function NMH cavitation agents for the treatment of breast cancer and biomaterial-associated infections. Through this research, I demonstrate how NMH can be strategically tuned to meet the demands of different clinical presentations by adjusting both the physicochemical properties of the nanoparticles and the acoustic protocols used for treatment. This work will establish NMH as a flexible, precise, and multi-functional treatment platform. Ultimately, this dissertation contributes to the development of a next-generation therapeutic approach that bridges the gap between mechanical ablation and drug delivery, all enabled through nanoparticle-mediated cavitation.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Biomedical Engineering
Department dc:contributor.department
Department of Biomedical Engineering and Mechanics
Grantor dc:publisher
Virginia Tech
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Hall, Sarah Louella
Chair dc:contributor.committeechair
  • Vlaisavljevich, Eli
Committee members dc:contributor.committeemember
  • Allen, Irving C.
  • Sheybani, Natasha
  • Durmaz, Yasemin
  • Munson, Jennifer M.

Subjects

dc:subject × 5

Rights

dc:rights
Statement dc:rights
  • In Copyright
Language dc:language.iso
en

Identifiers

dc:identifier.*
Dc Identifier Other
vt_gsexam:43562

Chain of custody

source
Harvested from
Virginia Tech
Base URL
vtechworks.lib.vt.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Hall, Sarah Louella. Investigation of Advanced Cavitation Agents for Nanoparticle-Mediated Histotripsy (NMH) Applications. doctoral thesis, Virginia Tech, 2025. https://hdl.handle.net/10919/134310